Double-Blind Placebo Controlled Study of Adjunctive Aripiprazole for Symptomatic Hyperprolactinemia In Premenopausal Women With Schizophrenia
NCT01338298
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Hyperprolactinemia
Interventions
DRUG:
Aripiprazole
DRUG:
Placebo
Sponsor
University of Maryland, Baltimore